Priority Date: 20.02.01 (US 20010270252P)

Artificial antigen presenting cell for preparing CD8 cell suspension for use in the treatment of cancer

  • Application ID: EP14187466
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.02.2001 - Priority Date (US 20010270252P)
  • 18.03.2015 - Publication A1 (EP2848255)